BNP/PUT/ELI LILLY & CO/1000/0.1/20.06.25 | Market Closed - Boerse Frankfurt Warrants 20:50:28 03/07/2024 BST | ||
| 14.59 EUR | +3.62% |
|
| Current month | +5.33% | ||
| 1 month | -19.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 03/07/24 | 14.63 | +3.91% |
| 02/07/24 | 14.08 | +3.23% |
| 01/07/24 | 13.64 | -1.80% |
| 28/06/24 | 13.89 | -0.50% |
| 27/06/24 | 13.96 | -2.31% |
Real-time Boerse Frankfurt Warrants
Last update July 03, 2024 at 08:50 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PC9XJJ |
| ISIN | DE000PC9XJJ3 |
| Date issued | 15/05/2024 |
| Strike | 1,000 $ |
| Maturity | 20/06/2025 (352 Days) |
| Parity | 10 : 1 |
| Emission price | 19.94 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 22.69 € |
|---|---|
| Lowest since issue | 13.42 € |
| Delta | -0.54x |
| Omega | 3.094 |
| Premium | 6.24x |
| Gearing | 5.68x |
| Moneyness | 1.113 |
| Difference Strike | 101.9 $ |
| Difference Strike % | +10.19% |
| Spread | 0.11 € |
| Spread % | 0.75% |
| Theoretical value | 14.66 |
| Implied Volatility | 33.48 % |
| Total Loss Probability | 36.44 % |
| Intrinsic value | 9.446 |
| Present value | 5.209 |
| Break even | 841.90 € |
| Theta | -0.07x |
| Vega | 0.31x |
| Rho | -0.35x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1
USD
Average target price
870.3
USD
Spread / Average Target
-3.10%
- Stock Market
- Warrants
- Warrant
